National Bank Of Canada Mirum Pharmaceuticals, Inc. Transaction History
National Bank Of Canada
- $62.9 Billion
- Q2 2024
A detailed history of National Bank Of Canada transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 20 shares of MIRM stock, worth $805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$805% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$262 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$201 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$176 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$146 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$130 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.48B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...